Author

Jamie A. Robyn

Observed names: J A Robyn, J ROBYN, J Robyn, J. A. Robyn, J. Robyn, JA ROBYN, Jamie Robyn

Institutions: United States Department of Veterans Affairs, Veterans Health Administration

Observed institutions: National Institutes of Health, Royal Children's Hospital, United States Department of Veterans Affairs, The University of Texas MD Anderson Cancer Center, The University of Melbourne, Veterans Health Administration, The Ohio State University Wexner Medical Center, University of Illinois Chicago, National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases, National Cancer Institute, Eunice Kennedy Shriver National Institute of Child Health and Human Development

OpenAlex ID: A5110023567

Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response Criteria

2007 · P. Valent, C. Akin, et al. · European Journal of Clinical Investigation · 750

HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome

2002 · Yogen Saunthararajah, Ryotaro Nakamura, et al. · Blood · 272

PDF

Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome

2003 · Amy D. Klion, Jamie Robyn, et al. · Blood · 240

PDF

Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis

2007 · Melody C. Carter, Jamie A. Robyn, et al. · Journal of Allergy and Clinical Immunology · 172

PDF

KIT D816V–associated systemic mastocytosis with eosinophilia and FIP1L1/PDGFRA-associated chronic eosinophilic leukemia are distinct entities

2007 · Irina Maric, Jamie Robyn, et al. · Journal of Allergy and Clinical Immunology · 111

PDF

Relapse following discontinuation of imatinib mesylate therapy for FIP1L1/PDGFRA-positive chronic eosinophilic leukemia: implications for optimal dosing

2007 · Amy D. Klion, Jamie Robyn, et al. · Blood · 100

PDF

Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis

2010 · T. M. Wilson, I. Maric, et al. · Haematologica · 94

PDF

Multilineage involvement of the fusion gene in patients with FIP1L1/PDGFRA‐positive hypereosinophilic syndrome

2005 · Jamie Robyn, Steven Lemery, et al. · British Journal of Haematology · 79

A pilot study of nonmyeloablative allogeneic hematopoietic stem cell transplant for advanced systemic mastocytosis

2006 · R Nakamura, S Chakrabarti, et al. · Bone Marrow Transplantation · 63

Activity of imatinib in systemic mastocytosis with chronic basophilic leukemia and a PRKG2-PDGFRB fusion

2007 · I. Lahortiga, C. Akin, et al. · Haematologica · 49

PDF

Systemic Mastocytosis

2006 · Jamie Robyn, Dean D. Metcalfe · Advances in immunology · 39

Exposure to domestic cats: risk factor for Pasteurella multocida peritonitis in liver cirrhosis?

1996 · C A Koch, C L Mabee, et al. · PubMed · 33

Cushing's syndrome in childhood and adolescence

1997 · JA ROBYN, CA KOCH, et al. · Journal of Paediatrics and Child Health · 21

Treatment of Systemic Mastocytosis

2006 · Todd M. Wilson, Dean D. Metcalfe, et al. · Immunology and Allergy Clinics of North America · 20

Imatinib-Responsive Hypereosinophilia in a Patient with B Cell ALL

2004 · Jamie Robyn, Pierre Noel, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 16

How do levels of (endogenous) glucocorticoids, interleukin‐10 and interleukin‐12 relate to multiple sclerosis relapse before, during and after pregnancy?

1999 · Christian A. Koch, Jamie A. Robyn, et al. · Clinical Endocrinology · 7

Lineage Analysis of the FIPL1-PDGFRα Fusion Gene in Myeloproliferative Hypereosinophilic Syndrome.

2004 · Steven J. Lemery, Jamie A. Robyn, et al. · Blood · 3

Cranial sinus thrombosis and preeclampsia

1997 · Christian A. Koch, Jamie A. Robyn, et al. · Journal of Stroke and Cerebrovascular Diseases · 3

Detection of c-Kit Mutation in Peripheral Blood vs. Bone Marrow Aspirates in Patients with Systemic Mastocytosis: Comparison Study of Pathological and Clinical Laboratory Findings in Patients with and without Detectable c-Kit Mutation in the Peripheral Blood.

2006 · Irina Maric, Jamie Robyn, et al. · Blood · 2

Intracranial venous thrombosis and proteinuria during pregnancy and puerperium

1999 · C. A. Koch, J. A. Robyn, et al. · Neurology · 2

Imatinib-responsive hypereosinophilic syndrome

2006 · Jamie Robyn · Leukemia Research · 1

Can the long-term prognosis of patients with seizures and structural brain lesions be improved by surgical treatment?

1999 · C.A. Koch, J. Robyn · Seizure · 1

Mastocytosis

2008 · Nataliya M. Kushnir‐Sukhov, Dean D. Metcalfe, et al.

Acquired Activating NRAS Mutations Associated with Aggressive Systemic Mastocytosis

2008 · T WILSON, Y WU, et al. · Journal of Allergy and Clinical Immunology

PDF

Systemic Mastocytosis with Eosinophilia: A Novel Diagnostic Approach To Distinguish Imatinib-Resistant Kit D816V-Associated Mast Cell Disease from Imatinib-Sensitive FIP1L1/PDGFRA-Associated Hypereosinophilic Syndrome.

2006 · Todd M. Wilson, Irina Maric, et al. · Blood

Works count: 26

Citation count: 2,078

H-index: 15

I10-index: 15